{"title":"局限性前列腺癌男性原发性雄激素剥夺治疗后的生存率","authors":"J. Zabell","doi":"10.1093/MED/9780190655341.003.0012","DOIUrl":null,"url":null,"abstract":"This chapter summarizes the findings of a population-based, observational study comparing men with clinically localized prostate cancer who received primary androgen-deprivation therapy (ADT) or were treated conservatively. The investigator used instrumental variable analysis to adjust for potential confounders. This study found no improvement in survival for men receiving primary ADT.","PeriodicalId":435097,"journal":{"name":"50 Studies Every Urologist Should Know","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer\",\"authors\":\"J. Zabell\",\"doi\":\"10.1093/MED/9780190655341.003.0012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This chapter summarizes the findings of a population-based, observational study comparing men with clinically localized prostate cancer who received primary androgen-deprivation therapy (ADT) or were treated conservatively. The investigator used instrumental variable analysis to adjust for potential confounders. This study found no improvement in survival for men receiving primary ADT.\",\"PeriodicalId\":435097,\"journal\":{\"name\":\"50 Studies Every Urologist Should Know\",\"volume\":\"17 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"50 Studies Every Urologist Should Know\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/MED/9780190655341.003.0012\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"50 Studies Every Urologist Should Know","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/MED/9780190655341.003.0012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer
This chapter summarizes the findings of a population-based, observational study comparing men with clinically localized prostate cancer who received primary androgen-deprivation therapy (ADT) or were treated conservatively. The investigator used instrumental variable analysis to adjust for potential confounders. This study found no improvement in survival for men receiving primary ADT.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
